
11 - 50 employees
Founded 2018
𧬠Biotechnology
π₯ Healthcare
π Pharmaceuticals
π₯ Funding within the last year
π° $30M Series A on 2026-05
Biotechnology β’ Healthcare β’ Pharmaceuticals
Secretome Therapeutics is a biotechnology company developing regenerative therapies derived from neonatal cardiac progenitor cells and their secretome. Their lead programsβSTM-01 (neonatal cell therapy) and STM-2 (secretome product)βare being developed for heart failure with preserved ejection fraction (HFpEF) and dilated cardiomyopathy (DCM). The company emphasizes near-zero donor variability, higher yield and potency from neonatal sources compared with adult stem cells, and an ethical, non-fetal cell source to enable consistent, scalable manufacturing. Secretome is conducting early-stage clinical trials and communicates an expanded access policy for investigational use.
π‘ We watch Secretome Therapeutics's careers page
Several times a day
how often we check
2
roles posted in the last 30 days
Selected: πΊπΈ United States β Remote USA.
Selected: π Date Added.
π₯ 3 minutes ago
Manufacturing executive leading GMP, CMC, CDMO, and clinical supply operations for Secretome Therapeutics' cell therapy pipeline. Building manufacturing capabilities for neonatal cardiac progenitor cell-derived therapies.
π€ Texas β Remote
π₯ Funding within the last year
π° $30M Series A on 2026-05
β° Full Time
π΄ Lead
π Director
π» Ghost score 15%
π₯ 3 minutes ago
Director of Data Management leading clinical trial data strategy, quality, and regulatory readiness. Supporting Secretome Therapeutics' neonatal cardiac progenitor cell therapies for DMD and heart failure.
πΊπΈ United States β Remote
π₯ Funding within the last year
π° $30M Series A on 2026-05
β° Full Time
π΄ Lead
π Director
π» Ghost score 15%